José Aristeu Fachini Frias

Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results

Kathryn Jean Lucas, Patricia López, Eric Lawitz et al. · Digestive and Liver Disease · 2020 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +17

Spinal Anesthesia for Cesarean Section. Use of Hyperbaric Bupivacaine (10mg) Combined with Different Adjuvants

Angélica Assunção Braga, José Aristeu Fachini Frias, Franklin Sarmento da Silva Braga et al. · Brazilian Journal of Anesthesiology · 2012 · 36 citations · Full text

Nursing, Anesthesiology, Surgery +17

MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study

Stephen A. Harrison, Sam Moussa, Mustafa R. Bashir et al. · Journal of Hepatology · 2018 · 34 citations

Medicine, Endocrinology, Pharmacotherapy +17

Spinal anesthesia for elective ceasarean section: use of different doses of hyperbaric bupivacaine associated with morphine and clonidine

Angélica de Fátima de Assunção Braga, José Aristeu Fachini Frias, Franklin Sarmento da Silva Braga et al. · Acta Cirúrgica Brasileira · 2013 · 28 citations · Full text

Medicine, Anesthesiology, Surgery +17

Association of lipophilic opioids and hyperbaric bupivacaine in spinal anesthesia for elective cesarean section. Randomized controlled study

Angélica de Fátima de Assunção Braga, Franklin Sarmento da Silva Braga, Eunice Sizue Hirata et al. · Acta Cirúrgica Brasileira · 2014 · 25 citations · Full text

Medicine, Anesthesiology, Surgery +17